Transforming Clinical Data Management with Clinical Data and Analytics Platforms

The clinical development landscape has become increasingly complex, evolving rapidly in response to post-pandemic demands, hybrid trial designs and the growing use of real-world data (RWD). These changes are driving the need for sponsors to conduct faster, more efficient trials while managing a rising volume of clinical data.

Adding to this complexity, ongoing trials across multiple therapy areas, many of which are outsourced to contract research organizations (CROs) can lead to sponsors having lower visibility over trial performance and progress. As regulatory expectations continue to evolve, particularly with the US Food and Drug Administration (FDA)’s review of International Council for Harmonisation (ICH) E6 (R3) guidelines, sponsors are under increased pressure to maintain oversight and ensure the quality, safety and integrity of their trials.

In this webinar, IQVIA SMEs, along with an Everest Group Industry Analyst, will dive into the pressing challenges sponsors face in clinical data management today. They will explore how an end-to-end unified clinical data and analytics (D&A) platform can offer a solution to sponsor challenges by acting as a single source of truth, offering a centralized hub to manage all aspects of their clinical trials in real time.

This webinar will also provide an opportunity for clinical trial stakeholders, including biopharma companies, MedTech enterprises and CROs to learn how they can harness the power of a unified D&A platform to navigate the complexities of modern clinical trials. The speakers will also delve into practical aspects that sponsors consider when deciding whether to deploy a clinical D&A platform, like evaluating return on investment (ROI) and key performance indicators (KPIs) to measure success.

They will also explore the role of next-gen technologies such as artificial intelligence (AI) and generative AI and how they are leveraged by these platforms to automate repetitive tasks and extract valuable insights for clinical trials.

Register for this webinar today to discover how clinical data management can be optimized to help sponsors navigate the complexities of modern clinical trials, improve oversight and ensure data quality.

Speakers

Nisarg Shah, Practice Director, Everest Group

Nisarg Shah is a Practice Director with the healthcare and life sciences team and manages Everest Group’s Clinical Development Technology outsourcing offerings. He focuses on advisory across the clinical development value chain.

Leveraging his significant consulting and research experience, he has advised many global service providers, product vendors and enterprises on digital transformation, product strategy and go-to-market strategy. He also has significant experience advising clients on mergers and acquisitions, competitor assessment and vendor assessment engagements.

He has authored industry reports on clinical development, decentralized clinical trials and D&A platforms and drives thought leadership pieces across the clinical technology space for the firm.

Message Presenter

Wendy Morahan, Sr. Director Product CDAS, IQVIA Technologies

Wendy has 25+ years experience in the life sciences industry with a career spanning academic research, preclinical drug discovery, and clinical trials, culminating in a focus and passion for delivering technology solutions that help bring treatments to patients faster.  Wendy is currently part of the product strategy leadership team for IQVIA Clinical Data Analytics Suite (CDAS), providing both SaaS solutions for the market as well as IQVIA’s internal CRO needs.  As part of the CDAS team, Wendy is responsible for strategy, product management leadership, and Go to Market activities.

Message Presenter